Articles by Disease (Endocarditis, Bacterial)

Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 9
Page: 104-111
Author(s): Rashi Chauhan, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain

Drainage of Cerebral Abscesses Prior to Valve Replacement in Stable Patients with Acute Left-Sided Infective Endocarditis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14
Page: 534-539
Author(s): Adrian Molnar, Ruxandra Beyer, Stefan Florian, Dafin F. Muresanu, Catalin Trifan, Ioan Muresan, Diana Sacui, Traian Scridon and Radu N. Balanescu

Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections

Journal: Current Pharmaceutical Design
Volume: 21
Page: 2058-2072
Author(s): Maria Magana, Anastasios Ioannidis, Emmanouil Magiorkinis, Oleg Ursu, Cristian G. Bologa, Stylianos Chatzipanagiotou, Michael R. Hamblin and George P. Tegos

Inhibition of Quorum Sensing in Staphylococcus spp.

Journal: Current Pharmaceutical Design
Volume: 21
Page: 2101-2108
Author(s): Gilles Brackman and Tom Coenye

Staphylococcus aureus: Current State of Prevalence, Impact, and Vaccine Development

Journal: Current Pharmaceutical Design
Volume: 21
Page: 2131-2135
Author(s): Meghan Brett and Steven B. Bradfute

Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections

Journal: Current Pharmaceutical Design
Volume: 21
Page: 2073-2088
Author(s): Haroon Mohammad, Shankar Thangamani and Mohamed N. Seleem

Driving Forces of Mechanisms Regulating Oxacillin-Resistance Phenotypes of MRSA: Truly Oxacillin-Susceptible mecA-Positive Staphylococcus aureus Clinical Isolates also Exist

Journal: Current Pharmaceutical Design
Volume: 21
Page: 2048-2053
Author(s): Spyros Pournaras, Artur J. Sabat, Hajo Grundmann, Ron Hendrix, Athanasios Tsakris and Alexander W. Friedrich